Victor Mitchell T, Faraji Farhoud, Voora Rohith, Kalavacherla Sandhya, Mell Loren K, Rose Brent S, Guo Theresa W
University of California San Diego School of Medicine San Diego California USA.
Northwestern University, Feinberg School of Medicine Chicago Illinois USA.
Laryngoscope Investig Otolaryngol. 2024 Aug 6;9(4):e1317. doi: 10.1002/lio2.1317. eCollection 2024 Aug.
A subset of laryngeal squamous cell carcinoma (LSCC) patients undergoing larynx preserving treatment ultimately require total laryngectomy (TL) for oncologic or functional reasons. This study aims to identify TL risk factors in these patients.
Retrospective cohort study using Veterans Affairs (VA) database. T1-T4 LSCC cases treated with primary radiotherapy (XRT) or chemoradiotherapy (CRT) were assessed for TL and recurrence. Binary logistic and Cox regression and Kaplan-Meier analyses were implemented.
Of 5390 cases, 863 (16.0%) underwent TL. On multivariable analysis, age (adjusted odds ratio: 0.97 [0.96-0.98]; < .001) and N3 disease (0.42 [0.18-1.00]; = .050) were associated with reduced risk of TL, whereas current alcohol use (1.22 [1.04-1.43]; = .015) and >T1 disease (T2, 1.76 [1.44-2.17]; < .001; T3, 2.06 [1.58-2.68]; < .001; T4, 1.79 [1.26-2.53]; = .001) were associated with increased risk of TL. However, N2 (adjusted hazard ratio: 1.30 [1.10-1.55]; = .003) and N3 (2.02 [1.25-3.26]; = .004) disease were associated with an increased risk for local recurrence. Compared to XRT, treatment with CRT was associated with reduced risk for local recurrence after adjusting for other factors (0.84 [0.70-0.99]; = .044). Those who do not receive TL following local recurrence have poorer disease-specific survival (log-rank, < .001). In patients without local recurrence, N2 disease was associated with a fourfold increase in risk of TL (4.24 [1.83-9.82]; < .001).
Advanced nodal stage was associated with reduced rates of salvage TL in the setting of local recurrence, and subsequent worse prognosis after recurrence. Conversely, advanced nodal stage may increase the risk for functional salvage TL in patients without recurrence.
Level 3.
一部分接受保喉治疗的喉鳞状细胞癌(LSCC)患者最终因肿瘤学或功能方面的原因需要进行全喉切除术(TL)。本研究旨在确定这些患者行全喉切除术的风险因素。
使用退伍军人事务部(VA)数据库进行回顾性队列研究。对接受原发性放疗(XRT)或放化疗(CRT)治疗的T1 - T4期LSCC病例进行全喉切除术和复发情况评估。采用二元逻辑回归、Cox回归和Kaplan - Meier分析。
在5390例病例中,863例(16.0%)接受了全喉切除术。多变量分析显示,年龄(调整优势比:0.97 [0.96 - 0.98];P < 0.001)和N3期疾病(0.42 [0.18 - 1.00];P = 0.050)与全喉切除术风险降低相关,而当前饮酒(1.22 [1.04 - 1.43];P = 0.015)和>T1期疾病(T2期,1.76 [1.44 - 2.17];P < 0.001;T3期,2.06 [1.58 - 2.68];P < 0.001;T4期,1.79 [1.26 - 2.53];P = 0.001)与全喉切除术风险增加相关。然而,N2期(调整风险比:1.30 [1.10 - 1.55];P = 0.003)和N3期(2.02 [1.25 - 3.26];P = 0.004)疾病与局部复发风险增加相关。与放疗相比,在调整其他因素后,放化疗与局部复发风险降低相关(0.84 [0.70 - 0.99];P = 0.044)。局部复发后未接受全喉切除术的患者疾病特异性生存率较差(对数秩检验,P < 0.001)。在无局部复发的患者中,N2期疾病与全喉切除术风险增加四倍相关(4.24 [1.83 - 9.82];P < 0.001)。
在局部复发的情况下,晚期淋巴结分期与挽救性全喉切除术的发生率降低相关,且复发后预后更差。相反,晚期淋巴结分期可能会增加无复发患者进行功能性挽救性全喉切除术的风险。
3级。